1. Home
  2. DVAX vs HPK Comparison

DVAX vs HPK Comparison

Compare DVAX & HPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVAX
  • HPK
  • Stock Information
  • Founded
  • DVAX 1996
  • HPK 2019
  • Country
  • DVAX United States
  • HPK United States
  • Employees
  • DVAX N/A
  • HPK N/A
  • Industry
  • DVAX Biotechnology: Pharmaceutical Preparations
  • HPK Oil & Gas Production
  • Sector
  • DVAX Health Care
  • HPK Energy
  • Exchange
  • DVAX Nasdaq
  • HPK Nasdaq
  • Market Cap
  • DVAX 1.2B
  • HPK 833.7M
  • IPO Year
  • DVAX 2004
  • HPK N/A
  • Fundamental
  • Price
  • DVAX $10.26
  • HPK $6.65
  • Analyst Decision
  • DVAX Buy
  • HPK Hold
  • Analyst Count
  • DVAX 4
  • HPK 3
  • Target Price
  • DVAX $26.50
  • HPK $11.67
  • AVG Volume (30 Days)
  • DVAX 1.3M
  • HPK 505.7K
  • Earning Date
  • DVAX 11-05-2025
  • HPK 11-05-2025
  • Dividend Yield
  • DVAX N/A
  • HPK 2.41%
  • EPS Growth
  • DVAX N/A
  • HPK N/A
  • EPS
  • DVAX N/A
  • HPK 0.86
  • Revenue
  • DVAX $316,268,000.00
  • HPK $964,232,000.00
  • Revenue This Year
  • DVAX $23.23
  • HPK N/A
  • Revenue Next Year
  • DVAX $16.57
  • HPK N/A
  • P/E Ratio
  • DVAX N/A
  • HPK $7.73
  • Revenue Growth
  • DVAX 26.66
  • HPK N/A
  • 52 Week Low
  • DVAX $9.20
  • HPK $6.13
  • 52 Week High
  • DVAX $14.63
  • HPK $15.72
  • Technical
  • Relative Strength Index (RSI)
  • DVAX 52.77
  • HPK 45.21
  • Support Level
  • DVAX $10.11
  • HPK $6.14
  • Resistance Level
  • DVAX $10.58
  • HPK $7.24
  • Average True Range (ATR)
  • DVAX 0.24
  • HPK 0.32
  • MACD
  • DVAX 0.03
  • HPK -0.02
  • Stochastic Oscillator
  • DVAX 62.50
  • HPK 43.78

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

About HPK HighPeak Energy Inc.

HighPeak Energy Inc is an independent crude oil and natural gas company focused on the development of unconventional oil and natural gas reserves in Howard County of the Midland Basin. The company operates in a single segment, which is crude oil and natural gas development, exploration, and production in the U.S.

Share on Social Networks: